1 Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-201.
2 王法,王宏辉.肝动脉化疗栓塞术联合射频消融术治疗小肝癌的研究进展[J].实用肿瘤学杂志,2013,27(5):447-451.
3 Chen X,Liu HP,Li M,et al.Advances in non-surgical management of primary liver cancer[J].World J Gastroenterol,2014,20(44):16630-16638.
4 Bosetti C,Turati F,La Vecchia C.Hepatocellular carcinoma epidemiology[J].Best Pract Res Clin Gastroenterol,2014,28(5):753-770.
5 Khan KN,Yatsuhashi H,Yamasaki K,et al.Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection[J].J Hepatol,2000,32(2):269-278.
6 Savastano S,Miotto D,Casarrubea G,et,a1.Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child′s grade A or grade B cirrhosis:a multivariate analysis of prognosis factors[J].J Clin Gastroenterol,1999,28(4):334-340.
7 Kurokochi K,Watannabe S,Masaki T,et al.Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation radiofrequency ablation alone for patients with hepatocellular carcinoma[J].World J Gastrogenterol,2005,11(10):1426-1432.
8 Yin XY,Lu MD.Percutaneous ablation for small hepatocellular carcinoma[J].Expert Rev Gastroenterol Hepatol,2009,3(2):121-130.
9 麦聪,唐云强,洪剑,等.原发性肝癌术后早期复发相关因素研究[J].临床合理用药,2012,6(5):26-29.
10 Lau WY,Leung TW,Yu SC,et al.Percutaneous local ablative therapy for hepatocellular carcinoma:a review and look into the future[J].Ann Surg,2003,237(2):171-179.
11 Yamaoto K,Masuzawa M,Kato M,et al.Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization[J].Cancer Chemother Pharmacol,1992,31(suppl):77-81.
12 Yamashita Y,Bekki Y,Imai D,et al.Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer[J].Thromb Res,2014,134(4):826-831.
13 Zhou L,Rui JA,Wang SB,et al.Risk factors of microvascular invasion,portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma[J].Hepatogastroenterology,2014,61(134):1696-1703.
14 Park HJ,Kim K,Chie EK,et al.Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery[J].Anticancer Res,2014,34(11):6685-6690.
15 Zhang L,Liu FY,Fu JX,et al.Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model[J].Int J Clin Exp Pathol,2014,7(11):7775-7781. |